글로벌 갑상선 질환 치료 시장 2023-2027 : 갑상선 기능 저하증, 갑상선 기능 항진증

■ 영문 제목 : Global Thyroid Gland Disorder Treatment Market 2023-2027

Technavio가 발행한 조사보고서이며, 코드는 IRTNTR45366-23 입니다.■ 상품코드 : IRTNTR45366-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 7월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (주문후 24시간내)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD2,500 ⇒환산￦3,375,000견적의뢰/주문/질문
Enterprise License (기업 열람용)USD4,000 ⇒환산￦5,400,000견적의뢰/주문/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 갑상선 질환 치료 시장 2023-2027
갑상선 질환 치료 시장은 2022년에서 2027년까지 8억 6,887만 달러로 성장하며, 예측 기간 동안 5.33%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 갑상선 질환 치료 시장의 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진 요인, 과제와 함께 약 25개 벤더를 대상으로 한 벤더 분석도 제공합니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 세계적인 갑상선 치료 인식 제고 프로그램 증가, 레보티록신 수요 증가, 요오드 결핍증 환자 증가 등이 시장을 주도하고 있습니다.

Technavio사의 갑상선 질환 치료 시장은 다음과 같이 세분화되어 있습니다.

유형별
- 갑상선 기능 저하증
- 갑상선 기능 항진증

유통 채널별
- 오프라인
- 온라인

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 보고서는 향후 몇 년 동안 갑상선 질환 치료 시장의 성장을 촉진하는 주요 이유 중 하나로 신흥국에 대한 관심 증가를 꼽고 있습니다. 또한, 비핵심 업무의 아웃소싱 증가와 천연물 의약품에 대한 관심이 높아지면서 시장 수요가 크게 증가할 것으로 예상됩니다.

갑상선 질환 치료 시장에 대한 연구 보고서는 다음과 같은 분야를 다루고 있습니다:
- 갑상선 질환 치료 시장 규모
- 갑상선 질환 치료 시장 예측
- 갑상선 질환 치료 시장 산업 분석

강력한 벤더 분석은 고객이 시장에서의 입지를 강화할 수 있도록 설계되었으며, 이에 따라 이 보고서에서는 Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Exelixis Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, IBSA Institute Biochimique SA, JEROME STEVENS PHARMACEUTICALS INC., Lannett Co. Inc., Lupin Ltd., Mayne Pharma Group Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., RLC Labs Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., 및 Viatris Inc. 등의 기업 정보를 수록하고 있습니다. 또한, 갑상선 질환 치료 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것으로 예상되고 있습니다.

이 연구는 업계 주요 참여자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.
■ 보고서 개요

1. 개요
2. 세계의 갑상선 질환 치료 시장 현황
3. 세계의 갑상선 질환 치료 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 유형별 시장 분석
7. 유통 채널별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global thyroid gland disorder treatment market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global thyroid gland disorder treatment market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Hypothyroidism – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hypothyroidism – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hypothyroidism – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hypothyroidism – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hypothyroidism – Year-over-year growth 2022-2027 (%)
o 6.4 Hyperthyroidism – Market size and forecast 2022-2027
o Exhibit 38: Chart on Hyperthyroidism – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Hyperthyroidism – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Hyperthyroidism – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hyperthyroidism – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 52: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 83: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 95: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 112: AbbVie Inc. – Overview
o Exhibit 113: AbbVie Inc. – Product / Service
o Exhibit 114: AbbVie Inc. – Key news
o Exhibit 115: AbbVie Inc. – Key offerings
o 12.5 Alvogen Iceland ehf
o Exhibit 116: Alvogen Iceland ehf – Overview
o Exhibit 117: Alvogen Iceland ehf – Product / Service
o Exhibit 118: Alvogen Iceland ehf – Key offerings
o 12.6 Exelixis Inc.
o Exhibit 119: Exelixis Inc. – Overview
o Exhibit 120: Exelixis Inc. – Product / Service
o Exhibit 121: Exelixis Inc. – Key offerings
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 122: Fresenius SE and Co. KGaA – Overview
o Exhibit 123: Fresenius SE and Co. KGaA – Business segments
o Exhibit 124: Fresenius SE and Co. KGaA – Key news
o Exhibit 125: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 126: Fresenius SE and Co. KGaA – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 127: GlaxoSmithKline Plc – Overview
o Exhibit 128: GlaxoSmithKline Plc – Business segments
o Exhibit 129: GlaxoSmithKline Plc – Key news
o Exhibit 130: GlaxoSmithKline Plc – Key offerings
o Exhibit 131: GlaxoSmithKline Plc – Segment focus
o 12.9 JEROME STEVENS PHARMACEUTICALS INC.
o Exhibit 132: JEROME STEVENS PHARMACEUTICALS INC. – Overview
o Exhibit 133: JEROME STEVENS PHARMACEUTICALS INC. – Product / Service
o Exhibit 134: JEROME STEVENS PHARMACEUTICALS INC. – Key offerings
o 12.10 Lannett Co. Inc.
o Exhibit 135: Lannett Co. Inc. – Overview
o Exhibit 136: Lannett Co. Inc. – Product / Service
o Exhibit 137: Lannett Co. Inc. – Key offerings
o 12.11 Lupin Ltd.
o Exhibit 138: Lupin Ltd. – Overview
o Exhibit 139: Lupin Ltd. – Product / Service
o Exhibit 140: Lupin Ltd. – Key news
o Exhibit 141: Lupin Ltd. – Key offerings
o 12.12 Mayne Pharma Group Ltd.
o Exhibit 142: Mayne Pharma Group Ltd. – Overview
o Exhibit 143: Mayne Pharma Group Ltd. – Business segments
o Exhibit 144: Mayne Pharma Group Ltd. – Key news
o Exhibit 145: Mayne Pharma Group Ltd. – Key offerings
o Exhibit 146: Mayne Pharma Group Ltd. – Segment focus
o 12.13 Merck KGaA
o Exhibit 147: Merck KGaA – Overview
o Exhibit 148: Merck KGaA – Business segments
o Exhibit 149: Merck KGaA – Key news
o Exhibit 150: Merck KGaA – Key offerings
o Exhibit 151: Merck KGaA – Segment focus
o 12.14 Novartis AG
o Exhibit 152: Novartis AG – Overview
o Exhibit 153: Novartis AG – Business segments
o Exhibit 154: Novartis AG – Key offerings
o Exhibit 155: Novartis AG – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 156: Pfizer Inc. – Overview
o Exhibit 157: Pfizer Inc. – Product / Service
o Exhibit 158: Pfizer Inc. – Key news
o Exhibit 159: Pfizer Inc. – Key offerings
o 12.16 RLC Labs Inc.
o Exhibit 160: RLC Labs Inc. – Overview
o Exhibit 161: RLC Labs Inc. – Product / Service
o Exhibit 162: RLC Labs Inc. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. – Overview
o Exhibit 164: Viatris Inc. – Business segments
o Exhibit 165: Viatris Inc. – Key news
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global thyroid gland disorder treatment market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Hypothyroidism – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hypothyroidism – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hypothyroidism – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hypothyroidism – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hyperthyroidism – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hyperthyroidism – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hyperthyroidism – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hyperthyroidism – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: AbbVie Inc. – Overview
Exhibits113: AbbVie Inc. – Product / Service
Exhibits114: AbbVie Inc. – Key news
Exhibits115: AbbVie Inc. – Key offerings
Exhibits116: Alvogen Iceland ehf – Overview
Exhibits117: Alvogen Iceland ehf – Product / Service
Exhibits118: Alvogen Iceland ehf – Key offerings
Exhibits119: Exelixis Inc. – Overview
Exhibits120: Exelixis Inc. – Product / Service
Exhibits121: Exelixis Inc. – Key offerings
Exhibits122: Fresenius SE and Co. KGaA – Overview
Exhibits123: Fresenius SE and Co. KGaA – Business segments
Exhibits124: Fresenius SE and Co. KGaA – Key news
Exhibits125: Fresenius SE and Co. KGaA – Key offerings
Exhibits126: Fresenius SE and Co. KGaA – Segment focus
Exhibits127: GlaxoSmithKline Plc – Overview
Exhibits128: GlaxoSmithKline Plc – Business segments
Exhibits129: GlaxoSmithKline Plc – Key news
Exhibits130: GlaxoSmithKline Plc – Key offerings
Exhibits131: GlaxoSmithKline Plc – Segment focus
Exhibits132: JEROME STEVENS PHARMACEUTICALS INC. – Overview
Exhibits133: JEROME STEVENS PHARMACEUTICALS INC. – Product / Service
Exhibits134: JEROME STEVENS PHARMACEUTICALS INC. – Key offerings
Exhibits135: Lannett Co. Inc. – Overview
Exhibits136: Lannett Co. Inc. – Product / Service
Exhibits137: Lannett Co. Inc. – Key offerings
Exhibits138: Lupin Ltd. – Overview
Exhibits139: Lupin Ltd. – Product / Service
Exhibits140: Lupin Ltd. – Key news
Exhibits141: Lupin Ltd. – Key offerings
Exhibits142: Mayne Pharma Group Ltd. – Overview
Exhibits143: Mayne Pharma Group Ltd. – Business segments
Exhibits144: Mayne Pharma Group Ltd. – Key news
Exhibits145: Mayne Pharma Group Ltd. – Key offerings
Exhibits146: Mayne Pharma Group Ltd. – Segment focus
Exhibits147: Merck KGaA – Overview
Exhibits148: Merck KGaA – Business segments
Exhibits149: Merck KGaA – Key news
Exhibits150: Merck KGaA – Key offerings
Exhibits151: Merck KGaA – Segment focus
Exhibits152: Novartis AG – Overview
Exhibits153: Novartis AG – Business segments
Exhibits154: Novartis AG – Key offerings
Exhibits155: Novartis AG – Segment focus
Exhibits156: Pfizer Inc. – Overview
Exhibits157: Pfizer Inc. – Product / Service
Exhibits158: Pfizer Inc. – Key news
Exhibits159: Pfizer Inc. – Key offerings
Exhibits160: RLC Labs Inc. – Overview
Exhibits161: RLC Labs Inc. – Product / Service
Exhibits162: RLC Labs Inc. – Key offerings
Exhibits163: Viatris Inc. – Overview
Exhibits164: Viatris Inc. – Business segments
Exhibits165: Viatris Inc. – Key news
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

※본 조사보고서 [글로벌 갑상선 질환 치료 시장 2023-2027 : 갑상선 기능 저하증, 갑상선 기능 항진증] (코드 : IRTNTR45366-23) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 갑상선 질환 치료 시장 2023-2027 : 갑상선 기능 저하증, 갑상선 기능 항진증] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

  • 글로벌 자율 무인 잠수정 (AUV) 시장 2023-2027 : 통신, 충돌 회피,내비게이션,추진,이미징
    IRTNTR75836-23 / Technavio / 2023년 6월 / 글로벌 자율 무인 잠수정 (AUV) 시장 2023-2027년 자율 무인 잠수정 (AUV) 시장은 2022년에서 2027년까지 19억 8,504만 달러 규모로 성장하여, 예측 기간 동안 16.85%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 자율...1. 개요 2. 세계의 자율 무인 잠수정 (AUV) 시장 현황 3. 세계의 자율 무인 잠수정 (AUV) 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 기술별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13....
  • 글로벌 불소 시장 2023-2027 : 제약 등급, 산업용 등급
    IRTNTR75995-23 / Technavio / 2023년 7월 / 글로벌 불소 시장 2023-2027 불소 시장은 2022년부터 2027년까지 1억 5,105만 달러로 성장하며, 예측 기간 동안 3.85%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 불소 시장에 대한 전반적인 분석, 시장 규모와 예측,...1. 개요 2. 세계의 불소 시장 현황 3. 세계의 불소 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록 ...
  • 글로벌 트렌볼론 에난네이트 시장 2023-2027 : 경구제, 주사제
    IRTNTR75740-23 / Technavio / 2023년 6월 / 세계의 트렌볼론 에난네이트 시장 2023-2027 트렌볼론 에난네이트 시장은 2022년부터 2027년까지 1,397만 달러로 성장하며, 예측 기간 동안 3.42%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 트렌볼론 에난네이트 시장의 전반적인 분석, 시장 규모...1. 개요 2. 세계의 트렌볼론 에난네이트 시장 현황 3. 세계의 트렌볼론 에난네이트 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록...
  • 글로벌 스타틴 시장 2023-2027 : 병원, 클리닉, 기타
    IRTNTR75841-23 / Technavio / 2023년 7월 / 글로벌 스타틴 시장 2023-2027 스타틴 시장은 2022년에서 2027년까지 26억 7661만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 3.36%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 스타틴 시장에 대한 전반적인 분석,...1. 개요 2. 세계의 스타틴 시장 현황 3. 세계의 스타틴 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 최종 용도별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록 ...
  • 글로벌 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 2023-2027 : 병원, 전문 클리닉, 재택 의료
    IRTNTR75785-23 / Technavio / 2023년 6월 / 글로벌 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 2023-2027 시신경 척수염 스펙트럼 장애 (NMOSD) 시장은 2022년에서 2027년까지 1억 7,348만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 6.16%의 CAGR을 기록할 것으로...1. 개요 2. 세계의 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 현황 3. 세계의 시신경 척수염 스펙트럼 장애 (NMOSD) 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 용도별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업...